Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Alzheimer's disease (AD) is a degenerative disease of the nervous system. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a drug used to treat type 2 diabetes, have been shown to have neuroprotective effects. This systematic review and meta-analysis evaluated the effects and potential me...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2023
|
| オンライン･アクセス: | https://doi.org/10.3389/fphar.2023.1205207 https://www.frontiersin.org/articles/10.3389/fphar.2023.1205207/pdf?isPublishedV2=False |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|